… Cholestyramine 4 g orally two to four times each day has been used in the management
of thyrotoxicosis due to reduced reabsorption of metabolized thyroid hormone from the …

… Glenn Matfin … G. Matfin has received research grants from Sanofi and Novo Nordisk. L.
Monnier has received lecture fees/honoraria from Sanofi, Eli Lilly and Novo Nordisk. …

Underutilization of glucose data and lack of easy and standardized glucose data collection,
analysis, visualization, and guided clinical decision making are key contributors to poor …

OBJECTIVE The association of idiopathic hypogonadotrophic hypogonadism (IHH) with
congenital olfactory deficit defines Kallmann's syndrome (KS). Although a small proportion of …

Hypercalcaemia is commonly seen in the context of parathyroid dysfunction and
malignancy and, when severe, can precipitate life-threatening sequelae. The differential of …

Background Recent data have suggested that serum uric acid (SUA) level is positively
associated with the development of type 2 diabetes (T2DM). Whether SUA is also independently …

Background: This 4-week, phase 3b, multicenter, open-label, single-arm, outpatient study
demonstrated the safe and effective use of the dulaglutide single-dose pen containing 0.5 mL …

The American Diabetes Association (ADA)" Standards of Care in Diabetes" includes the
ADA's current clinical practice recommendations and is intended to provide the components of …

Background: Recent studies have shown that diabetes is a major risk factor that contributes
to the severity of COVID-19 and resulting mortality. Poor glycemic control is also associated …

Type 2 diabetes mellitus is epidemic in most developed and many developing countries. The
associated morbidity, mortality and high costs of care, make type 2 diabetes an important …